← Open Payments lookup

ZANA DELIC: Open Payments

NPI 1528313749 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$697 in 34 payments from 14 companies in 2025. Trend: 2023 $918 · 2024 $995 · 2025 $697

Food & beverage: $697
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.5$101
Neurocrine BioSciences, Inc.5$100
E.R. Squibb & Sons, L.L.C.4$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
Otsuka America Pharmaceutical, Inc.3$57
Axsome Therapeutics, Inc.2$49
Teva Pharmaceuticals USA, Inc.2$46
Alkermes, Inc.2$41
ABBVIE INC.2$30
Collegium Pharmaceutical, Inc.2$28

Products named: TRINTELLIX, INGREZZA, COBENFY, CAPLYTA, Auvelity, AUSTEDO XR, REXULTI, VRAYLAR.

Industry payments across ID — which companies pay providers there.